Back to 
Bank of New York Mellon Corp
Bank of New York Mellon Corp
SABS1 quarters
Position history for Bank of New York Mellon Corp's holdings in SAB BIOTHERAPEUTICS INC
Bank of New York Mellon Corp holds 107,847 shares of SABS (SAB BIOTHERAPEUTICS INC), worth $420,604 as of 2026-Q2. This is a new position. SABS represents 0.0% of Bank of New York Mellon Corp's portfolio.
Current Value
$420,604
Current Shares
107,847
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.